NCT02578680 2024-09-20MK-3475-189Merck Sharp & Dohme LLCPhase 3 Completed616 enrolled 19 charts 1 FDA
NCT03349333 2019-10-01A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLMundipharma (China) Pharmaceutical Co. LtdPhase 3 Completed85 enrolled 26 charts
NCT00806819 2017-02-02Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCBoehringer IngelheimPhase 3 Completed718 enrolled 21 charts
NCT00659269 2016-02-26A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer PatientsNew Mexico Cancer Research AlliancePhase 3 Completed319 enrolled 7 charts